|
MechanismPeptidoglycan modulators |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Suzhou Phagelux Bio-tech Company Limited
0 Patents (Medical) associated with Suzhou Phagelux Bio-tech Company Limited
100 Deals associated with Suzhou Phagelux Bio-tech Company Limited
100 Translational Medicine associated with Suzhou Phagelux Bio-tech Company Limited